🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This Phase 3 study was intended to demonstrate superiority of either sotagl...
Status
Completed
Location
Lexicon Investigational Site
Start Date
2015-03
Trial ID
NCT02384941
Treatments Being Tested
This Phase 1 study is intended to assess the pharmacodynamics (PD), pharmac...
Status
Completed
Location
Lexicon Investigational Site
Start Date
2012-03
Trial ID
NCT01555008
Treatments Being Tested
The purpose of this study is to assess the effect of LX4211 and the compara...
Status
Completed
Location
Lexicon Investigational Site
Start Date
2013-08
Trial ID
NCT01916863
Treatments Being Tested
The primary objective of this study is to evaluate the safety and tolerabil...
Status
Completed
Location
Lexicon Investigational Site
Start Date
2013-08
Trial ID
NCT01916850
Treatments Being Tested
This Phase 1 study is to investigate the effects of higher doses of LX4211 ...
Status
Completed
Location
Lexicon Investigational Site
Start Date
2013-07
Trial ID
NCT01913002
Treatments Being Tested
The main purpose of the study is to determine the changes in symptoms and f...
Status
Active Not Recruiting
Location
Lexicon Investigational Site (4041)
Start Date
2024-09-24
Trial ID
NCT06481891
Treatments Being Tested
This Phase 3 study was intended to demonstrate superiority of either Sotagl...
Status
Completed
Location
Lexicon Investigational Site
Start Date
2015-05
Trial ID
NCT02421510
Treatments Being Tested
This Phase 3 study was designed to demonstrate the net benefit of sotaglifl...
Status
Completed
Location
Lexicon Investigational Site
Start Date
2015-09
Trial ID
NCT02531035
Treatments Being Tested
The primary purpose of this study is to evaluate the pharmacodynamics of LX...
Status
Completed
Location
Lexicon Investigational Site
Start Date
2011-03
Trial ID
NCT01334242
Treatments Being Tested
This Phase 2 study was intended to demonstrate superiority of sotagliflozin...
Status
Completed
Location
Lexicon Investigational Site
Start Date
2015-04
Trial ID
NCT02383940
Treatments Being Tested